Monthly Archives: July 2010
45th Anniversary of Medicare and Medicaid
Today marks the 45th Anniversary of the enactment of Medicare and Medicaid. Since 1965, millions of Americans, including women diagnosed with ovarian cancer, have received health insurance through these two programs. Americans aged 65 or older are eligible for Medicare; … Continue reading
Posted in Blog Leave a comment
Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening
Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening Background:Women’s awareness of ovarian cancer (OC) risks, their attitudes towards and beliefs about … Continue reading
My Summer Internship with OCNA
Hi Everyone, As I approach my final weeks as an Ovarian Cancer National Alliance Events Intern I thought I would share with the organization my experience. When I started here at the beginning of June everyone was in full swing … Continue reading
Posted in Blog Leave a comment
A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
Ovarian cancer (OC) is the single most deadly form of women’s cancer, typically presenting as an advanced disease at diagnosis in part due to a lack of known risk factors or genetic markers of risk. The KRAS oncogene and altered … Continue reading
Ovarian Cancer Development and Metastasis (Am. J. Pathol.)
The biology of ovarian carcinoma differs from that of hematogenously metastasizing tumors because ovarian cancer cells primarily disseminate within the peritoneal cavity and are only superficially invasive. However, since the rapidly proliferating tumors compress visceral organs and are only temporarily … Continue reading
Posted in News Tagged early detection, outcomes, prevention, science, symptoms, treatment Leave a comment
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6-12 months) subpopulation of OVA-301 phase III randomized trial.
BACKGROUND: OVA-301 is a large randomized trial that showed superiority of trabectedin plus pegylated liposomal doxorubicin (PLD) over PLD alone in relapsed ovarian cancer. The optimal management of patients with partially platinum-sensitive relapse [6-12 months platinum-free interval (PFI)] is unclear. … Continue reading
Book: Outside the Lines…of Love, Life and Cancer available now!
Click to purchase Outside The Lines . . . of Love, Life, and Cancer is a riveting tale of surviving one of life’s most terrifying illnesses, ovarian cancer. The reader is taken on a most intimate journey, feeling firsthand the … Continue reading
Posted in Blog Leave a comment
Ovarian cancer survivors share trials but focus on triumphs at Dallas hospital’s support group
Becky Teter shrieks as the women spill into the conference room for their regular gathering. “Oh, Lisa made it! Yea!” The women laugh and smile and clap. “And Louise! Ahh! Yes!” The women laugh and smile and clap some more. … Continue reading
FDA Laboratory Tests
Earlier this week, the Food and Drug Administration (FDA) held a two-day meeting on laboratory tests. This meeting covered the regulation of various types of tests, including laboratory developed tests, in vitro diagnostics and direct to consumer genetic tests. One … Continue reading
Posted in News Leave a comment
An update on Provenge and the FDA
Provenge, a vaccine to treat the recurrence of prostate cancer, has been approved by the Food and Drug Administration (FDA). The vaccine is made from a patient’s own blood cells with cancer cells and an immune boosting substance. A three … Continue reading
Posted in News 11 Comments
Action is Teal – Advocacy Day Wrap Up!
On July 13th, more than 110 advocates clad in teal from across the nation congregated on Capitol Hill to ask their elected officials to support ovarian cancer-related legislation and funding requests. Before advocates went to visit the offices of their … Continue reading
Posted in Blog Leave a comment
Teal Bracelets, designed by Angela Moore, now available!
The popular Angela Moore hand-painted teal bracelets from our 2010 Power is Teal Conference are now available for purchase, while supplies last. These exclusive teal bracelets are going fast … hurry and get yours today! Here is how to order: … Continue reading
Posted in Blog Leave a comment
